MedPath

Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial

Not Applicable
Recruiting
Conditions
Myopia
Interventions
Device: Multifocal contact lenses
Device: Single vision contact lenses
Registration Number
NCT05159765
Lead Sponsor
Visioneering Technologies, Inc
Brief Summary

This is a multi-center, randomized, double-masked clinical trial. All study devices are market approved/cleared in the localities where the study is conducted. Subjects will be randomly assigned to wear NaturalVue Sphere single vision contact lenses (SVCL) or NaturalVue Multifocal (NVMF) soft contact lenses for a total of three years.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
144
Inclusion Criteria
  1. Male or female, aged 7 to <13 (inclusive) at the Screening/Baseline examination.

  2. Meet the following refractive criteria determined by cycloplegic autorefraction at Screening/Baseline:

    • Spherical Equivalent Refractive Error (SERE): between -0.75 and -5.00 D inclusive.
    • Astigmatism: ≀ -0.75 D
    • Anisometropia: < 1.000
Exclusion Criteria
  1. Has previously worn or currently wears rigid or gas permeable contact lenses, including orthokeratology lenses,
  2. Appears to exhibit poor personal hygiene, that, in the Investigator's opinion, might prevent safe contact lens wear.
  3. Is currently, or within 30 days prior to this study has been, an active participant in another clinical study.
  4. Current or prior use of bifocals, progressive addition lenses, atropine, pirenzepine, multifocal or specialized contact lenses, or ANY other myopia control treatment.
  5. The Investigator for any reason considers that it is not in the best interest of the subject to participate in the study, including if the child is not mature enough to independently handle and care for soft contact lenses.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TreatmentMultifocal contact lensesContact lens with refractive correction, multifocal optic
ControlSingle vision contact lensesContact lens with refractive correction, single vision optic
Primary Outcome Measures
NameTimeMethod
Change in Refractive Error relative to BaselineBaseline, 12, 24, 36 months

Mean change in cycloplegic auto-refraction (D)

Secondary Outcome Measures
NameTimeMethod
Change in Axial LengthBaseline,12, 24, 36 months

Mean change in Axial Length (mm)

Trial Locations

Locations (8)

Myopia Specialist Centre

πŸ‡ΈπŸ‡¬

Singapore, Singapore

Fig Garden Optometry

πŸ‡ΊπŸ‡Έ

Fresno, California, United States

Toronto Eye Care

πŸ‡¨πŸ‡¦

Toronto, Ontario, Canada

North Suburban Vision Consultants

πŸ‡ΊπŸ‡Έ

Deerfield, Illinois, United States

Cooper Eye Care

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Bellaire Family Eye Care

πŸ‡ΊπŸ‡Έ

Bellaire, Texas, United States

University of Waterloo School of Optometry

πŸ‡¨πŸ‡¦

Waterloo, Ontario, Canada

Hong Kong Polytechnic University

πŸ‡­πŸ‡°

Tsim Sha Tsui, Hong Kong

Β© Copyright 2025. All Rights Reserved by MedPath